InvestorsHub Logo
icon url

olden_grumpini

11/12/21 11:50 AM

#384052 RE: Rdunn88 #384050

The Aspire deal requires a minimum closing price of $0.10. The Aspire deal expires in July 2022. They call it the "maturity" date.
icon url

Hugon

11/12/21 2:10 PM

#384083 RE: Rdunn88 #384050

There’s probably one last gap rally left in this stock in the .20-.40 range. It could be in 2022. The smartest thing the morons of Wakefield could do is sell the entire company for $150M. A highly reasonable price for a pharma to change IP and explore all asset indications. If they engaged with someone like Locust Walk, they could probably find a buyer in that range. I just don’t think Leo is smart enough to do such. He has the brains of a lowland ground animal, the integrity of a Madolf and the reputation of a con man. His creative writing team is in the same camp. The belief of the lab studies that they can’t let go of is rather pathetic. Morons.